Gene: TBC1D10A
Official Full Name: TBC1 domain family member 10Aprovided by HGNC
Gene Summary: Enables PDZ domain binding activity. Involved in activation of cysteine-type endopeptidase activity and retrograde transport, endosome to Golgi. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25340 | TBC1D10A Knockout cell line (HeLa) | Human | TBC1D10A | 1:3~1:6 | Negative | Online Inquiry |
KO25341 | TBC1D10A Knockout cell line (HCT 116) | Human | TBC1D10A | 1:2~1:4 | Negative | Online Inquiry |
KO25342 | TBC1D10A Knockout cell line (HEK293) | Human | TBC1D10A | 1:3~1:6 | Negative | Online Inquiry |
KO25343 | TBC1D10A Knockout cell line (A549) | Human | TBC1D10A | 1:3~1:4 | Negative | Online Inquiry |
TBC1D10A Gene Knockout Cell Lines are genetically modified cellular models designed to facilitate the study of the TBC1D10A gene's role in various biological processes, particularly in cellular signal transduction and membrane trafficking. By employing the CRISPR/Cas9 gene editing technology, these cell lines have been established to ensure the precise knockout of the TBC1D10A gene, enabling researchers to investigate the functional consequences of gene loss in a controlled environment.
The primary function of these knockout cell lines lies in their ability to mimic the loss-of-function scenarios in vivo, allowing researchers to elucidate the downstream effects of TBC1D10A on key signaling pathways. TBC1D10A is known to be involved in regulating small GTPase activity and has implications in diseases including cancer and neurodegenerative disorders. By utilizing these cell lines, scientists can identify pathological mechanisms, screen for potential therapeutic compounds, and understand the gene's role in cellular homeostasis and pathology.
In scientific research and clinical developments, TBC1D10A Gene Knockout Cell Lines serve as invaluable tools for drug discovery and functional genomics studies. They stand out compared to traditional cell lines due to their specificity in targeting the TBC1D10A gene, thereby providing a clearer understanding of its biological implications without the confounding effects of gene redundancy that often complicate interpretations in wild-type models.
The utility of these knockout cell lines is underscored by their potential to yield insights into novel therapeutic strategies and biomarkers, making them an indispensable asset for researchers and clinicians alike who are investigating the intricate dynamics of gene expression and regulation. Our company prides itself on offering high-quality, meticulously validated biological products that empower advancement in life sciences, establishing us as a leader in genetic engineering solutions for research excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.